Medicilon is a professional preclinical integrated R&D contract research organization (CRO) that provides a full range of one-stop R&D services to pharmaceutical companies and institutions worldwide. They are committed to supporting partners throughout their drug discovery journey, offering services such as pharmacokinetics, preclinical research, drug screening, and safety assessment. Recently, Medicilon has also received international accreditation by obtaining the OECD GLP certificate, demonstrating its compliance with global standards. Medicilon has supported more than 500 successful IND submissions, and more than 75 US FDA fully approved medicines since beginning in 2004.